Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Cg Oncology Inc (NASDAQ: CGON) was $29.72 for the day, down -2.62% from the previous closing price of $30.52. In other words, the price has decreased by -$2.62 from its previous closing price. On the day, 0.55 million shares were traded. CGON stock price reached its highest trading level at $31.5 during the session, while it also had its lowest trading level at $29.71.
Ratios:
Our analysis of CGON’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 35.32 and its Current Ratio is at 35.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $60.
On September 23, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $66.
On August 28, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $65.ROTH MKM initiated its Buy rating on August 28, 2024, with a $65 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 16 ’24 when Song Hong Fang sold 700,000 shares for $28.00 per share. The transaction valued at 19,600,000 led to the insider holds 3,003,931 shares of the business.
POST LEONARD E sold 1,000 shares of CGON for $28,840 on Dec 16 ’24. The Director now owns 0 shares after completing the transaction at $28.84 per share. On Dec 06 ’24, another insider, POST LEONARD E, who serves as the Director of the company, sold 1,000 shares for $34.54 each. As a result, the insider received 34,542 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2323476736 and an Enterprise Value of 1469539968. For the stock, the TTM Price-to-Sale (P/S) ratio is 3505.34 while its Price-to-Book (P/B) ratio in mrq is 3.74. Its current Enterprise Value per Revenue stands at 2148.45 whereas that against EBITDA is -15.318.
Stock Price History:
The Beta on a monthly basis for CGON is 1.28, which has changed by -0.17890769 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, CGON has reached a high of $50.23, while it has fallen to a 52-week low of $25.77. The 50-Day Moving Average of the stock is -10.65%, while the 200-Day Moving Average is calculated to be -14.53%.
Shares Statistics:
CGON traded an average of 617.36K shares per day over the past three months and 838650 shares per day over the past ten days. A total of 67.54M shares are outstanding, with a floating share count of 42.10M. Insiders hold about 37.74% of the company’s shares, while institutions hold 61.82% stake in the company. Shares short for CGON as of 1734048000 were 4988157 with a Short Ratio of 8.08, compared to 1731628800 on 5396401. Therefore, it implies a Short% of Shares Outstanding of 4988157 and a Short% of Float of 7.4499995.
